Prognostic value of a lncRNA signature in early-stage invasive breast cancer patients
The integrated model combining 5-lncRNA molecular signature with clinical parameters demonstrates significant prognostic stratification capacity and therapeutic decision-making value in EBC management. It may help patients consult and personalize disease management.
Authors
- Nan Lan
- Yiyin Tang (ORCID: https://orcid.org/0009-0000-9461-9418)
- Jiaying Zou
- Yan Yuan (ORCID: https://orcid.org/0000-0002-3064-1955)
- Ming Li (ORCID: https://orcid.org/0000-0001-6291-9328)
- Guojun Zhang (ORCID: https://orcid.org/0000-0003-4911-5784)
- Xiting Wang (ORCID: https://orcid.org/0000-0001-5768-1095)
- Rong Guo (ORCID: https://orcid.org/0000-0002-7342-3237)
- Zeying Li (ORCID: https://orcid.org/0000-0003-3788-3727)
- Jianyun Nie (ORCID: https://orcid.org/0000-0003-3691-8940)
- Yinju Yang
Institutions
- Kunming Medical University (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1186/s12935-025-03832-9
- Citations
- 1
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- National Natural Science Foundation of China
- Kunming Medical University
- Yunnan Provincial Science and Technology Department